Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals - 34 Year Stock Price History | REGN

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Regeneron Pharmaceuticals as of January 16, 2025 is 693.23.
  • The all-time high Regeneron Pharmaceuticals stock closing price was 1201.76 on August 27, 2024.
  • The Regeneron Pharmaceuticals 52-week high stock price is 1211.20, which is 74.7% above the current share price.
  • The Regeneron Pharmaceuticals 52-week low stock price is 666.25, which is 3.9% below the current share price.
  • The average Regeneron Pharmaceuticals stock price for the last 52 weeks is 960.59.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Regeneron Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 711.4800 715.1900 733.5900 690.8700 693.2300 -2.68%
2024 968.2929 905.0000 1201.7600 701.8500 712.3300 -18.90%
2023 783.8250 720.4700 881.7000 680.4900 878.2900 21.73%
2022 662.5164 627.1000 766.3900 548.3500 721.4900 14.25%
2021 558.3248 482.8600 680.9600 446.7300 631.5200 30.72%
2020 532.3580 373.3500 658.2100 336.1800 483.1100 28.66%
2019 343.5064 372.4400 439.5700 273.4600 375.4800 0.53%
2018 351.6680 382.6000 408.5100 284.6000 373.5000 -0.65%
2017 422.4830 379.7000 526.5300 340.7500 375.9600 2.42%
2016 394.5000 516.5500 519.4800 331.0500 367.0900 -32.38%
2015 498.7331 410.1600 592.4000 396.8900 542.8700 32.33%
2014 333.6675 274.5900 434.9500 267.6200 410.2500 49.05%
2013 239.8612 181.2000 316.6320 158.4200 275.2400 60.89%
2012 130.8339 56.4300 187.7400 56.4300 171.0700 208.62%
2011 51.1067 33.8200 72.1900 32.6100 55.4300 68.84%
2010 26.2129 24.6300 33.6900 20.7900 32.8300 35.77%
2009 17.7172 18.7000 24.7400 12.0500 24.1800 31.70%
2008 18.9787 23.5600 24.7500 13.3500 18.3600 -23.98%
2007 20.5494 19.8100 28.6000 13.6600 24.1500 20.33%
2006 16.1155 15.9000 24.2800 11.1200 20.0700 26.23%
2005 8.2982 9.0400 16.8300 4.6300 15.9000 72.64%
2004 10.8352 15.0500 16.7200 6.8500 9.2100 -37.39%
2003 14.7557 19.0900 22.3050 5.8800 14.7100 -20.53%
2002 18.8848 27.9200 29.3100 11.3600 18.5100 -34.27%
2001 28.3779 35.5600 39.0000 20.6000 28.1600 -20.16%
2000 27.3401 12.3100 56.5000 11.6300 35.2700 176.63%
1999 7.8169 7.9380 12.7500 5.5630 12.7500 72.88%
1998 8.1477 8.8750 10.9400 5.8750 7.3750 -13.87%
1997 9.8900 17.1300 19.3800 6.5000 8.5630 -46.88%
1996 16.2382 13.2500 24.6250 11.8750 16.1200 26.43%
1995 9.5972 3.3130 16.9400 3.3130 12.7500 325.00%
1994 7.0362 15.2500 17.2500 3.0000 3.0000 -80.65%
1993 15.5031 12.0000 21.5000 11.0000 15.5000 29.17%
1992 13.0192 18.7500 22.5000 8.0000 12.0000 -33.81%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $76.580B $13.117B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.957B 13.64
Bristol Myers Squibb (BMY) United States $113.233B 47.72
Gilead Sciences (GILD) United States $112.014B 20.29
Vertex Pharmaceuticals (VRTX) United States $105.474B 0.00
CSL (CSLLY) Australia $84.378B 0.00
GSK (GSK) United Kingdom $68.581B 7.94
Argenex SE (ARGX) Netherlands $39.617B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.695B 0.00
BioNTech SE (BNTX) Germany $29.452B 0.00
Biogen (BIIB) United States $21.686B 9.31
Illumina (ILMN) United States $21.679B 79.01
BeiGene (ONC) Cayman Islands $17.250B 0.00
Moderna (MRNA) United States $16.259B 0.00
Genmab (GNMSF) Denmark $14.669B 17.59
Genmab (GMAB) Denmark $14.658B 21.50
Incyte (INCY) United States $13.590B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.841B 29.81
Sarepta Therapeutics (SRPT) United States $11.920B 107.58
Insmed (INSM) United States $11.673B 0.00
Bio-Techne Corp (TECH) United States $11.648B 44.98
Exact Sciences (EXAS) United States $10.457B 0.00
Exelixis (EXEL) United States $10.287B 23.39
QIAGEN (QGEN) Netherlands $10.196B 20.98
Vaxcyte (PCVX) United States $10.106B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Intra-Cellular Therapies (ITCI) United States $10.058B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.547B 32.45
Repligen (RGEN) United States $8.676B 113.04
Ascendis Pharma (ASND) Denmark $7.840B 0.00
Roivant Sciences (ROIV) United Kingdom $7.738B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.340B 7.18
Revolution Medicines (RVMD) United States $7.028B 0.00
Halozyme Therapeutics (HALO) United States $6.718B 15.17
Legend Biotech (LEGN) United States $6.140B 0.00
Blueprint Medicines (BPMC) United States $5.554B 0.00
Cytokinetics (CYTK) United States $5.502B 0.00
Nuvalent (NUVL) United States $5.443B 0.00
Telix Pharmaceuticals (TLX) Australia $4.897B 0.00
Alkermes (ALKS) Ireland $4.543B 15.26
Guardant Health (GH) United States $4.535B 0.00
TG Therapeutics (TGTX) United States $4.496B 0.00
Krystal Biotech (KRYS) United States $4.398B 72.82
ADMA Biologics Inc (ADMA) United States $4.387B 46.40
Viking Therapeutics (VKTX) United States $4.381B 0.00
Alvotech (ALVO) Luxembourg $4.076B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.885B 0.00
Axsome Therapeutics (AXSM) United States $3.879B 0.00
Scholar Rock Holding (SRRK) United States $3.790B 0.00
Arcellx (ACLX) United States $3.736B 0.00
Biohaven (BHVN) United States $3.713B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.672B 0.00
Avidity Biosciences (RNA) United States $3.515B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.452B 0.00
Immunovant (IMVT) United States $3.447B 0.00
Apellis Pharmaceuticals (APLS) United States $3.413B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.388B 0.00
SpringWorks Therapeutics (SWTX) United States $3.199B 0.00
Merus (MRUS) Netherlands $3.002B 0.00
NovoCure (NVCR) Jersey $2.970B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.960B 0.00
Vericel (VCEL) United States $2.937B 991.67
Xenon Pharmaceuticals (XENE) Canada $2.928B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.872B 22.13
Zai Lab (ZLAB) China $2.769B 0.00
Denali Therapeutics (DNLI) United States $2.749B 0.00
Amicus Therapeutics (FOLD) United States $2.695B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.620B 0.00
Twist Bioscience (TWST) United States $2.588B 0.00
Kymera Therapeutics (KYMR) United States $2.472B 0.00
Janux Therapeutics (JANX) United States $2.454B 0.00
Vera Therapeutics (VERA) United States $2.344B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.301B 0.00
CG Oncology (CGON) United States $2.296B 0.00
Edgewise Therapeutics (EWTX) United States $2.287B 0.00
Beam Therapeutics (BEAM) United States $2.185B 0.00
Protagonist Therapeutics (PTGX) United States $2.182B 13.76
Bavarian Nordic (BVNRY) Denmark $2.175B 13.33
IDEAYA Biosciences (IDYA) United States $2.077B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.014B 0.00
Ligand Pharmaceuticals (LGND) United States $2.008B 50.13
Mirum Pharmaceuticals (MIRM) United States $1.984B 0.00
Mesoblast (MESO) Australia $1.970B 0.00
Agios Pharmaceuticals (AGIO) United States $1.963B 0.00
Iovance Biotherapeutics (IOVA) United States $1.951B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.931B 16.05
Geron (GERN) United States $1.916B 0.00
NeoGenomics (NEO) United States $1.896B 0.00
Apogee Therapeutics (APGE) United States $1.848B 0.00
Disc Medicine (IRON) United States $1.763B 0.00
WAVE Life Sciences (WVE) Singapore $1.760B 0.00
Akero Therapeutics (AKRO) United States $1.734B 0.00
Belite Bio (BLTE) United States $1.713B 0.00
Certara (CERT) United States $1.708B 48.23
Galapagos (GLPG) Belgium $1.690B 0.00
ImmunityBio (IBRX) United States $1.686B 0.00
MannKind (MNKD) United States $1.679B 43.50
Vir Biotechnology (VIR) United States $1.666B 0.00
Dynavax Technologies (DVAX) United States $1.660B 97.15
Fortrea Holdings (FTRE) United States $1.632B 51.97
Arcutis Biotherapeutics (ARQT) United States $1.616B 0.00
Celldex Therapeutics (CLDX) United States $1.615B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.521B 0.00
Novavax (NVAX) United States $1.492B 0.00
Structure Therapeutics (GPCR) United States $1.446B 0.00
Viridian Therapeutics (VRDN) United States $1.442B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.439B 0.00
Travere Therapeutics (TVTX) United States $1.412B 0.00
Myriad Genetics (MYGN) United States $1.350B 0.00
Arcus Biosciences (RCUS) United States $1.299B 0.00
Nurix Therapeutics (NRIX) United States $1.292B 0.00
Arvinas (ARVN) United States $1.279B 0.00
MiMedx (MDXG) United States $1.271B 33.27
Day One Biopharmaceuticals (DAWN) United States $1.190B 0.00
Praxis Precision Medicines (PRAX) United States $1.177B 0.00
ANI Pharmaceuticals (ANIP) United States $1.157B 15.77
Spyre Therapeutics (SYRE) United States $1.155B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.119B 0.00
Intellia Therapeutics (NTLA) United States $1.039B 0.00
Liquidia Technologies (LQDA) United States $1.032B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.015B 0.00
Adaptive Biotechnologies (ADPT) United States $0.959B 0.00
Pacira BioSciences (PCRX) United States $0.953B 8.97
Anavex Life Sciences (AVXL) United States $0.952B 0.00
CureVac (CVAC) Germany $0.943B 7.65
Nuvation Bio (NUVB) United States $0.936B 0.00
Gyre Therapeutics (GYRE) United States $0.934B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.919B 0.00
Zymeworks (ZYME) United States $0.911B 0.00
Cytek Biosciences (CTKB) United States $0.878B 0.00
Cogent Biosciences (COGT) United States $0.866B 0.00
AbCellera Biologics (ABCL) Canada $0.862B 0.00
Oculis Holding AG (OCS) Switzerland $0.857B 0.00
Castle Biosciences (CSTL) United States $0.847B 151.25
ArriVent BioPharma (AVBP) United States $0.838B 0.00
Sana Biotechnology (SANA) United States $0.817B 0.00
Septerna (SEPN) United States $0.799B 0.00
Avid Bioservices (CDMO) United States $0.794B 0.00
Bicara Therapeutics (BCAX) United States $0.783B 0.00
Tyra Biosciences (TYRA) United States $0.769B 0.00
Immatics (IMTX) Germany $0.767B 0.00
Replimune (REPL) United States $0.757B 0.00
Upstream Bio (UPB) United States $0.734B 0.00
Pliant Therapeutics (PLRX) United States $0.731B 0.00
Dianthus Therapeutics (DNTH) United States $0.716B 0.00
Prothena (PRTA) Ireland $0.702B 0.00
89BIO (ETNB) United States $0.691B 0.00
CorMedix Inc (CRMD) United States $0.679B 0.00
UniQure (QURE) Netherlands $0.675B 0.00
Erasca (ERAS) United States $0.669B 0.00
Immunome (IMNM) United States $0.662B 0.00
Pharming Group (PHAR) Netherlands $0.659B 0.00
Cullinan Therapeutics (CGEM) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
LENZ Therapeutics (LENZ) United States $0.638B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.628B 0.00
Arbutus Biopharma (ABUS) United States $0.623B 0.00
CARGO Therapeutics (CRGX) United States $0.621B 0.00
GRAIL (GRAL) United States $0.596B 0.00
Tectonic Therapeutic (TECX) United States $0.592B 0.00
Keros Therapeutics (KROS) United States $0.590B 0.00
Humacyte (HUMA) United States $0.580B 0.00
Kura Oncology (KURA) United States $0.569B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.569B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.562B 0.00
Oric Pharmaceuticals (ORIC) United States $0.562B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.551B 0.00
Entrada Therapeutics (TRDA) United States $0.548B 9.21
Rapport Therapeutics (RAPP) United States $0.542B 0.00
Emergent Biosolutions (EBS) United States $0.535B 0.00
Annexon (ANNX) United States $0.515B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.508B 0.00
Mineralys Therapeutics (MLYS) United States $0.491B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.487B 0.00
MeiraGTx Holdings (MGTX) United States $0.485B 0.00
Opthea (OPT) Australia $0.480B 0.00
Stoke Therapeutics (STOK) United States $0.477B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.475B 0.00
MaxCyte (MXCT) United States $0.465B 0.00
MBX Biosciences (MBX) United States $0.457B 0.00
GH Research (GHRS) Ireland $0.446B 0.00
Celcuity (CELC) United States $0.443B 0.00
Kodiak Sciences (KOD) United States $0.438B 0.00
AnaptysBio (ANAB) United States $0.432B 0.00
Allogene Therapeutics (ALLO) United States $0.431B 0.00
Alpha Teknova (TKNO) United States $0.430B 0.00
Cartesian Therapeutics (RNAC) United States $0.428B 0.00
Kamada (KMDA) Israel $0.426B 26.46
Terns Pharmaceuticals (TERN) United States $0.426B 0.00
PureTech Health (PRTC) United States $0.421B 0.00
Astria Therapeutics (ATXS) United States $0.420B 0.00
Abivax SA (ABVX) France $0.404B 0.00
ChromaDex (CDXC) United States $0.403B 527.00
Prime Medicine (PRME) United States $0.386B 0.00
Aura Biosciences (AURA) United States $0.380B 0.00
Third Harmonic Bio (THRD) United States $0.376B 0.00
REGENXBIO (RGNX) United States $0.372B 0.00
Codexis (CDXS) United States $0.357B 0.00
Neumora Therapeutics (NMRA) United States $0.357B 0.00
Northwest Biotherapeutics (NWBO) United States $0.354B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.350B 0.00
Eton Pharmaceuticals (ETON) United States $0.350B 0.00
Precigen (PGEN) United States $0.344B 0.00
Contineum Therapeutics (CTNM) United States $0.343B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.342B 0.00
Sage Therapeutics (SAGE) United States $0.340B 0.00
Zenas BioPharma (ZBIO) United States $0.339B 0.00
Revance Therapeutics (RVNC) United States $0.339B 0.00
EnGene Holdings (ENGN) Canada $0.336B 0.00
Alumis (ALMS) United States $0.331B 0.00
Absci (ABSI) United States $0.328B 0.00
Tango Therapeutics (TNGX) United States $0.314B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.309B 0.00
Voyager Therapeutics (VYGR) United States $0.298B 7.68
XOMA Royalty (XOMA) United States $0.297B 0.00
ATyr Pharma (ATYR) United States $0.296B 0.00
Trevi Therapeutics (TRVI) United States $0.294B 0.00
Prima BioMed (IMMP) Australia $0.293B 0.00
Chimerix (CMRX) United States $0.292B 0.00
Neurogene (NGNE) United States $0.291B 0.00
Olema Pharmaceuticals (OLMA) United States $0.289B 0.00
Rezolute (RZLT) United States $0.284B 0.00
ITeos Therapeutics (ITOS) United States $0.284B 0.00
Atea Pharmaceuticals (AVIR) United States $0.276B 0.00
AC Immune (ACIU) Switzerland $0.269B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.268B 0.00
Candel Therapeutics (CADL) United States $0.266B 0.00
C4 Therapeutics (CCCC) United States $0.259B 0.00
Design Therapeutics (DSGN) United States $0.256B 0.00
Benitec Biopharma (BNTC) United States $0.255B 0.00
Verastem (VSTM) United States $0.255B 0.00
Semper Paratus Acquisition (TVGN) United States $0.254B 0.00
BioStem Technologies (BSEM) $0.250B 22.06
Compass Therapeutics (CMPX) United States $0.244B 0.00
Sangamo Therapeutics (SGMO) United States $0.243B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.241B 0.00
Urogen Pharma (URGN) United States $0.240B 0.00
Foghorn Therapeutics (FHTX) United States $0.239B 0.00
Fulcrum Therapeutics (FULC) United States $0.236B 0.00
Lifecore Biomedical (LFCR) United States $0.233B 0.00
Ocugen (OCGN) United States $0.229B 0.00
Anika Therapeutics (ANIK) United States $0.228B 0.00
Artiva Biotherapeutics (ARTV) United States $0.227B 0.00
Amarin (AMRN) Ireland $0.227B 0.00
DiaMedica Therapeutics (DMAC) United States $0.225B 0.00
Nautilus Biotechnology (NAUT) United States $0.221B 0.00
Gossamer Bio (GOSS) United States $0.220B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.208B 0.00
ACELYRIN, INC (SLRN) United States $0.207B 0.00
Inhibrx Biosciences (INBX) United States $0.206B 0.00
TuHURA Biosciences (HURA) United States $0.205B 0.00
Molecular Partners AG (MOLN) Switzerland $0.201B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.198B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.196B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.189B 0.00
Cardiff Oncology (CRDF) United States $0.185B 0.00
Adocia (ADOCY) France $0.183B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.182B 0.00
GENFIT S.A (GNFT) France $0.180B 0.00
BioAge Labs (BIOA) United States $0.177B 0.00
Alector (ALEC) United States $0.176B 0.00
Bright Minds Biosciences (DRUG) United States $0.172B 0.00
ScPharmaceuticals (SCPH) United States $0.170B 0.00
Coherus BioSciences (CHRS) United States $0.169B 0.00
Cidara Therapeutics (CDTX) United States $0.169B 0.00
Fate Therapeutics (FATE) United States $0.167B 0.00
Nkarta (NKTX) United States $0.166B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
Adherex Technologies (FENC) United States $0.163B 0.00
Puma Biotechnology (PBYI) United States $0.162B 6.90
Actuate Therapeutics (ACTU) United States $0.162B 0.00
Sagimet Biosciences (SGMT) United States $0.159B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.159B 0.00
Checkpoint Therapeutics (CKPT) United States $0.154B 0.00
Sutro Biopharma (STRO) United States $0.153B 0.00
Akoya Biosciences (AKYA) United States $0.150B 0.00
Kyverna Therapeutics (KYTX) United States $0.149B 0.00
Caribou Biosciences (CRBU) United States $0.149B 0.00
TScan Therapeutics (TCRX) United States $0.148B 0.00
Ventyx Biosciences (VTYX) United States $0.147B 0.00
Solid Biosciences (SLDB) United States $0.147B 0.00
Innate Pharma S.A (IPHA) France $0.147B 0.00
Compugen (CGEN) Israel $0.146B 82.00
Biomea Fusion (BMEA) United States $0.144B 0.00
Seres Therapeutics (MCRB) United States $0.144B 0.00
Seer (SEER) United States $0.142B 0.00
Zura Bio (ZURA) United States $0.141B 0.00
Climb Bio (CLYM) United States $0.134B 0.00
Monopar Therapeutics (MNPR) United States $0.134B 0.00
InflaRx (IFRX) Germany $0.131B 0.00
Instil Bio (TIL) United States $0.130B 0.00
2seventy Bio (TSVT) United States $0.128B 0.00
Inozyme Pharma (INZY) United States $0.128B 0.00
Renovaro (RENB) United States $0.126B 0.00
IGM Biosciences (IGMS) United States $0.124B 0.00
INmune Bio (INMB) United States $0.122B 0.00
Aligos Therapeutics (ALGS) United States $0.121B 0.00
XBiotech (XBIT) United States $0.118B 0.00
Alto Neuroscience (ANRO) United States $0.117B 0.00
Leap Therapeutics (LPTX) United States $0.117B 0.00
Tenaya Therapeutics (TNYA) United States $0.116B 0.00
Inventiva S.A (IVA) France $0.114B 0.00
Elutia (ELUT) United States $0.113B 0.00
Nuvectis Pharma (NVCT) United States $0.112B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.111B 0.00
TELA Bio (TELA) United States $0.111B 0.00
Black Diamond Therapeutics (BDTX) United States $0.109B 0.00
Vor Biopharma (VOR) $0.107B 0.00
Jasper Therapeutics (JSPR) United States $0.106B 0.00
Editas Medicine (EDIT) United States $0.104B 0.00
Cellectis S.A (CLLS) France $0.103B 0.00
DBV Technologies S.A (DBVT) France $0.102B 0.00
HilleVax (HLVX) United States $0.102B 0.00
Cabaletta Bio (CABA) United States $0.101B 0.00
23andMe Holding (ME) United States $0.100B 0.00
BioHarvest Sciences (BHST) Canada $0.100B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.099B 0.00
X4 Pharmaceuticals (XFOR) United States $0.097B 0.00
PepGen (PEPG) United States $0.097B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
MediciNova (MNOV) United States $0.096B 0.00
Cue Biopharma (CUE) United States $0.096B 0.00
Alpha Cognition (ACOG) Canada $0.095B 0.00
Immunic (IMUX) United States $0.095B 0.00
ALX Oncology Holdings (ALXO) United States $0.093B 0.00
Atara Biotherapeutics (ATRA) United States $0.090B 0.00
Genelux (GNLX) United States $0.089B 0.00
Mersana Therapeutics (MRSN) United States $0.089B 0.00
Adverum Biotechnologies (ADVM) United States $0.089B 0.00
Aadi Bioscience (AADI) United States $0.089B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.089B 0.00
Entera Bio (ENTX) Israel $0.088B 0.00
Scilex Holding (SCLX) United States $0.087B 0.00
Genenta Science S.p.A (GNTA) Italy $0.087B 0.00
Allakos (ALLK) United States $0.087B 0.00
Theratechnologies (THTX) Canada $0.086B 0.00
Adagene (ADAG) China $0.086B 0.00
I-Mab (IMAB) China $0.086B 0.00
Skye Bioscience (SKYE) United States $0.084B 0.00
VistaGen Therapeutics (VTGN) United States $0.083B 0.00
Citius Oncology (CTOR) United States $0.082B 0.00
Bluebird Bio (BLUE) United States $0.082B 0.00
BGM Group (BGM) China $0.082B 0.00
CAMP4 Therapeutics (CAMP) United States $0.082B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.082B 0.00
Applied Therapeutics (APLT) United States $0.079B 0.00
Quince Therapeutics (QNCX) United States $0.079B 0.00
Adicet Bio (ACET) United States $0.076B 0.00
Ikena Oncology (IKNA) United States $0.075B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
Aerovate Therapeutics (AVTE) United States $0.074B 0.00
Adlai Nortye (ANL) Cayman Islands $0.073B 0.00
Vigil Neuroscience (VIGL) United States $0.073B 0.00
Agenus (AGEN) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Rani Therapeutics Holdings (RANI) United States $0.072B 0.00
Invizyne Technologies (IZTC) United States $0.071B 0.00
Abpro Holdings (ABP) United States $0.070B 0.00
Oncolytics Biotech (ONCY) Canada $0.070B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
CytomX Therapeutics (CTMX) United States $0.069B 5.18
Annovis Bio (ANVS) United States $0.067B 0.00
Galena Biopharma (SLS) United States $0.067B 0.00
Elicio Therapeutics (ELTX) United States $0.066B 0.00
FibroBiologics (FBLG) United States $0.066B 0.00
BeyondSpring (BYSI) United States $0.065B 0.00
Immuneering (IMRX) United States $0.064B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
Generation Bio (GBIO) United States $0.062B 0.00
Werewolf Therapeutics (HOWL) United States $0.062B 0.00
Connect Biopharma Holdings (CNTB) United States $0.060B 0.00
Oncobiologics (OTLK) United States $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.059B 0.00
Ovid Therapeutics (OVID) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
IO Biotech (IOBT) Denmark $0.057B 0.00
Shattuck Labs (STTK) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Invivyd (IVVD) United States $0.054B 0.00
Boundless Bio (BOLD) United States $0.054B 0.00
Spero Therapeutics (SPRO) United States $0.053B 14.00
PDS Biotechnology (PDSB) United States $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.052B 0.00
Dyadic (DYAI) United States $0.049B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.049B 0.00
Xilio Therapeutics (XLO) United States $0.048B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
Celularity (CELU) United States $0.047B 0.00
Rapt Therapeutics (RAPT) United States $0.046B 0.00
Aileron Therapeutics (ALRN) United States $0.046B 0.00
Opus Genetics (IRD) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
Precision BioSciences (DTIL) United States $0.044B 0.00
Clene (CLNN) United States $0.043B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Lantern Pharma (LTRN) United States $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Passage Bio (PASG) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
Q32 Bio (QTTB) United States $0.041B 0.00
Omega Therapeutics (OMGA) United States $0.039B 0.00
Rallybio (RLYB) United States $0.039B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.038B 0.00
Lexaria Bioscience (LEXX) Canada $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.037B 0.00
Enzo Biochem (ENZ) United States $0.036B 0.00
SAB Biotherapeutics (SABS) United States $0.035B 0.00
Promis Neurosciences (PMN) Canada $0.034B 0.00
Intensity Therapeutics (INTS) United States $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
RenovoRx (RNXT) United States $0.032B 0.00
Cognition Therapeutics (CGTX) United States $0.032B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.031B 0.00
Chemomab Therapeutics (CMMB) Israel $0.030B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
UNITY Biotechnology (UBX) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Curis (CRIS) United States $0.029B 0.00
LakeShore Biopharma (LSB) China $0.029B 0.00
Beyond Air (XAIR) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.027B 0.00
Longeveron (LGVN) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
BioAtla (BCAB) United States $0.026B 0.00
OnKure Therapeutics (OKUR) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Exicure (XCUR) United States $0.025B 0.00
Prana Biotechnology (ATHE) Australia $0.024B 0.00
Pluri (PLUR) Israel $0.024B 0.00
IN8bio (INAB) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Gelteq (GELS) Australia $0.022B 0.00
NextCure (NXTC) United States $0.022B 0.00
Ocean Biomedical (OCEA) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Athira Pharma (ATHA) United States $0.022B 0.00
Cara Therapeutics (CARA) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Bolt Biotherapeutics (BOLT) United States $0.021B 0.00
Aprea Therapeutics (APRE) United States $0.020B 0.00
Affimed (AFMD) Germany $0.019B 0.00
BioXcel Therapeutics (BTAI) United States $0.019B 0.00
Palvella Therapeutics (PVLA) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
BRIACELL THERAP (BCTX) Canada $0.018B 0.00
MetaVia (MTVA) United States $0.018B 0.00
NKGen Biotech (NKGN) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Spruce Biosciences (SPRB) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Aptose Biosciences (APTO) Canada $0.013B 0.00
Hoth Therapeutics (HOTH) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
CervoMed (CRVO) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.013B 0.00
BioAffinity Technologies (BIAF) United States $0.013B 0.00
Mustang Bio (MBIO) United States $0.012B 0.00
Eyenovia (EYEN) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Apollomics (APLM) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
Carmell (CTCX) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Mainz Biomed (MYNZ) Germany $0.009B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Silo Pharma (SILO) United States $0.008B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Vincerx Pharma (VINC) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00